Second, we speculate that the elevated levels of GFAP and NfL in the blood may reflect neuroaxonal or astrocytic damage in an active pathological state, such as TBI (Shahim et al., 2024) and MS (Kuhle et al., 2019). This evidence concerns the gene GFAP and myeloid sarcoma.